Merger Monday returns ...
It's been a while since several deals have been simultaneously announced at the beginning of the week but there is a possibility of it happening today.
That's because overnight the likes of the Wall Street Journal, the Financial Times and Bloomberg were all reporting US-listed biopharmaceutical company Amgen is close to buying Horizon Therapeutics for around $116.5 a share or around $26 billion. Below are the relevant links:..
Register for free to see rest of this article and all public articles from BetavilleLogin / Register
Date: Monday, 12 December 2022, 10:07 am